Health

Results: 4837-4848 of 8802

Azafaros Announces Key Scientific Oral and Poster Presentations on Nizubaglustat Accepted for WORLDSymposium™ 2025

PR Newswire associated0

Neurizon's NUZ-001 Reduces Aggregation of Key ALS Disease Target TDP-43 in Preclinical Study

Essity expands its athletics tape production in France

Nagase Viita to Launch Injectable-grade Pharmaceutical Excipient "SUCROSE SG" in 2025

ONWARD Medical Awarded Grant to Study Potential for ARC-BCI Therapy to Restore Movement after Stroke

Louis Denis, M.D., Chief Medical Officer, Byondis (Photo: Business Wire)

Byondis Appoints Louis Denis, M.D., as Chief Medical Officer

PR Newswire associated0

Telix to Add FAP-Targeting Candidates to Theranostic Pipeline

Business Wire logo

Silence Therapeutics Presents Late-Breaking Phase 2 Zerlasiran Data at 2024 American Heart Association (AHA) Annual Meeting

ACCESSWIRE associated0

Leadership Evolution Announced by EW Healthcare Partners

Business Wire logo

Aktana Named a Leader and Star Performer in Everest Group’s 2024 Life Sciences Next-generation Customer Engagement Platforms (CEPs) PEAK Matrix®

VelaVigo Announces Exclusive Option Agreement with Avenzo to License a Potential First-in-Class Nectin4/TROP2 Bispecific Antibody-Drug Conjugate

Business Wire logo

Novotech Releases Comprehensive Report on the Global Clinical Trial Landscape for Small Cell Lung Cancer (SCLC)